Logo image of ABVE

ABOVE FOOD INGREDIENTS INC (ABVE) Stock Fundamental Analysis

USA - NASDAQ:ABVE - CA00373V1004 - Common Stock

1.64 USD
-0.03 (-1.8%)
Last: 9/12/2025, 8:00:00 PM
1.6405 USD
+0 (+0.03%)
After Hours: 9/12/2025, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, ABVE scores 2 out of 10 in our fundamental rating. ABVE was compared to 89 industry peers in the Food Products industry. ABVE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ABVE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ABVE has reported negative net income.
ABVE had a positive operating cash flow in the past year.
ABVE had negative earnings in each of the past 5 years.
ABVE had negative operating cash flow in 4 of the past 5 years.
ABVE Yearly Net Income VS EBIT VS OCF VS FCFABVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

ABVE's Return On Assets of -325.21% is on the low side compared to the rest of the industry. ABVE is outperformed by 96.59% of its industry peers.
ABVE's Return On Equity of -402.64% is on the low side compared to the rest of the industry. ABVE is outperformed by 88.64% of its industry peers.
Industry RankSector Rank
ROA -325.21%
ROE -402.64%
ROIC N/A
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABVE Yearly ROA, ROE, ROICABVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

ABVE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABVE Yearly Profit, Operating, Gross MarginsABVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5 -10

More info and screens

5

2. Health

2.1 Basic Checks

ABVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABVE remains at a similar level compared to 1 year ago.
The debt/assets ratio for ABVE is higher compared to a year ago.
ABVE Yearly Shares OutstandingABVE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ABVE Yearly Total Debt VS Total AssetsABVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ABVE has an Altman-Z score of 31.74. This indicates that ABVE is financially healthy and has little risk of bankruptcy at the moment.
ABVE's Altman-Z score of 31.74 is amongst the best of the industry. ABVE outperforms 98.86% of its industry peers.
The Debt to FCF ratio of ABVE is 0.31, which is an excellent value as it means it would take ABVE, only 0.31 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ABVE (0.31) is better than 92.05% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that ABVE is not too dependend on debt financing.
ABVE has a better Debt to Equity ratio (0.05) than 76.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.31
Altman-Z 31.74
ROIC/WACCN/A
WACC6.92%
ABVE Yearly LT Debt VS Equity VS FCFABVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

ABVE has a Current Ratio of 0.04. This is a bad value and indicates that ABVE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.04, ABVE is doing worse than 96.59% of the companies in the same industry.
A Quick Ratio of 0.04 indicates that ABVE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.04, ABVE is doing worse than 96.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
ABVE Yearly Current Assets VS Current LiabilitesABVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

ABVE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.13%.
ABVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 61.96%.
EPS 1Y (TTM)-81.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)61.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABVE Yearly Revenue VS EstimatesABVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100M 200M 300M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ABVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABVE Price Earnings VS Forward Price EarningsABVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 35.9
EV/EBITDA N/A
ABVE Per share dataABVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ABVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABOVE FOOD INGREDIENTS INC

NASDAQ:ABVE (9/12/2025, 8:00:00 PM)

After market: 1.6405 +0 (+0.03%)

1.64

-0.03 (-1.8%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-18 2024-11-18
Earnings (Next)N/A N/A
Inst Owners12.27%
Inst Owner Change-50.05%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap83.95M
AnalystsN/A
Price TargetN/A
Short Float %2.64%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF 35.9
P/OCF 17.02
P/B 5.38
P/tB 5.38
EV/EBITDA N/A
EPS(TTM)-2.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY2.79%
OCF(TTM)0.1
OCFY5.87%
SpS9.06
BVpS0.3
TBVpS0.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -325.21%
ROE -402.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 0.5%
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover24.7
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.31
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 31.74
F-Score3
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)61.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y664.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1290.72%
OCF growth 3YN/A
OCF growth 5YN/A